凱鉀力寧散

국가: 대만

언어: 중국어

출처: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

유효 성분:

SODIUM POLYSTYRENE SULFONATE

제공처:

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356)

ATC 코드:

V03AE01

약제 형태:

散劑

구성:

SODIUM POLYSTYRENE SULFONATE (4018000200) MG

패키지 단위:

瓶裝

수업:

製　劑

처방전 유형:

須由醫師處方使用

Manufactured by:

SANOFI-AVENTIS FRANCE 1-13, BOULEVARD ROMAIN ROLLAND 75014 PARIS, FRANCE FR

치료 영역:

polystyrene sulfonate

치료 징후:

高鉀血症及由尿少症和由急性腎壞死（如腎小管病變、腎血色蛋白尿性變、猝變性腎病、壓碎性腎病所引起的尿閉症、高鉀血症）

제품 요약:

註銷日期: 2018/07/03; 註銷理由: 自請註銷; 有效日期: 2019/07/28; 英文品名: RESONIUM-A POWDER

승인 상태:

已註銷

승인 날짜:

1999-07-28

환자 정보 전단

RESONIUM-A
Brand of sodium polystyrene sulfonate
COMPOSITION
Resonium A is ground and flavoured sodium polystyrene
sulphonate. It is a buff-colored powder with a pleasant
vanilla
odour
and
sweet
taste.
Available
in
lever-lid
H.D.P.E. containers of 454g Resonium A together with a
plastic
scoop
which,
when
filled
level,
contains
approximately 15g.
CLINICAL PARTICULARS
THERAPEUTIC INDICATIONS
Resonium
A
is
an
ion-exchange
resin
that
is
recommended
for
the
treatment
of
hyperkalaemia
associated with anuria or severe oliguria. It is also used
to treat hyperkalaemia in patients requiring dialysis and
in patients on regular haemodialysis or on prolonged
peritoneal dialysis.
POSOLOGY AND METHOD OF ADMINISTRATION
Resonium A is for oral or rectal administration only.
The dosage recommendations detailed in this section are
a guide only; the precise requirements should be decided
on the basis of regular serum electrolyte determinations.
Adults, including the elderly:
Oral
The usual dose is 15g, three or four times a day. The
resin is given by mouth in a little water, or it may be
made into a paste with some sweetened vehicle.
Rectal
In cases where vomiting may make oral administration
difficult, the resin may be given rectally as a suspension
of
30g
resin
in
100ml
2%
methylcellulose
450
BP
(medium viscosity) and 100ml water, as a daily retention
enema. In the initial stages administration by this route
as well as orally may help to achieve a more rapid
lowering of the serum potassium level.
The enema should if possible be retained for at least nine
hours following which the colon should be irrigated to
remove the resin. If both routes are used initially it is
probably unnecessary to continue rectal administration
once the oral resin has reached the rectum.
Children:
Oral
1g/kg
body
weight
daily
in
divided
doses
for
acute
hyperkalaemia. Dosage may be reduced to 0.5g/kg of
body
weight
daily
in
divided
doses
for
maintenance
therapy.
The resin is given orally, preferably with a drink (not a
fruit squash because of the high potass